文献速递生殖医学

激光辅助孵化对玻璃化/复温囊胚的影响:ALADDIN随机对照试验

The effect of laser-assisted hatching on vitrified/warmed blastocysts: the ALADDIN randomized controlled trial.
PubMed 文献 · Fertil Steril · 2024-02-09

ALADDIN为一项双中心平行随机对照研究,纳入698例18-39岁、接受非供卵体外受精并计划行玻璃化/复温囊胚择期单胚胎移植的女性,比较激光辅助孵化与对照组的活产率。辅助孵化组活产率29.8%(105/352),对照组29.2%(101/346),活产的相对风险为1.02(95%CI 0.86-1.19)。结论认为激光辅助孵化不能提高玻璃化/复温囊胚的活产率,需进一步研究排除特定亚组中可能存在的轻微获益。

要点

  • 激光辅助孵化组活产率29.8%(105/352),对照组29.2%(101/346),活产相对风险1.02(95%CI 0.86-1.19)。
  • 探索性亚组分析未发现任何临床情况可从复温囊胚的辅助孵化中获益。
  • 作者结论认为激光辅助孵化不能提高玻璃化/复温囊胚的活产率。

核心结论

  • 在接受玻璃化/复温囊胚冻融胚胎移植的患者中,激光辅助孵化不能提高活产率。
  • 需进一步研究以排除特定患者亚组中可能存在的较轻微但值得关注的获益。

研究设计与样本

  • ALADDIN为双中心平行随机对照比较研究,设置于大学医院。
  • 2018年9月至2021年11月期间招募参与者,年龄18-39岁,接受非供卵体外受精周期,计划行玻璃化/复温囊胚择期单胚胎移植。
  • 排除子宫异常、体重指数>35 kg/m2、严重男性因素不孕或行植入前遗传学检测者。
  • 共698例符合纳入标准并随机分组:辅助孵化组352例,对照组346例。

主要发现

  • 辅助孵化组活产105例(29.8%),对照组活产101例(29.2%)。
  • 辅助孵化组活产的相对风险为1.02(95%CI 0.86-1.19)。
  • 针对女性年龄、招募中心、体外受精指征、授精方式、囊胚质量和囊胚发育天数的探索性亚组分析,未发现任何临床情况可从复温囊胚的辅助孵化中获益。

关键数值与推荐

  • 辅助孵化使用1,480 nm二极管激光,从1-5点钟位置以连续0.2 ms脉冲去除约三分之一的透明带。
  • 主要结局为活产率;次要终点包括临床妊娠、流产、多胎妊娠、早产、产科和新生儿并发症及先天异常。

局限性

  • 原文结论提出需进一步研究以排除特定患者亚组中可能存在的较轻微但值得关注的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether laser-mediated assisted hatching (AH) performed on vitrified/warmed blastocysts before embryo transfer can improve live birth rate. DESIGN: The "pArtiaL zonA pelluciDa removal by assisteD hatchINg of blastocysts (ALADDIN)" is a 2-center comparative study with a parallel randomized controlled design. SETTING: University hospital. PATIENTS: Participants were recruited between September 2018 and November 2021. They were aged 18-39 years, underwent nondonor in vitro fertilization cycles, and were scheduled for elective single embryo transfer with vitrified/warmed blastocysts. Those with uterine abnormalities, body mass index of >35 kg/m2, severe male factor infertility, or performing preimplantation genetic testing were excluded. INTERVENTION: Assisted hatching was performed using a 1,480 nm diode laser, removing approximately one-third of the zona pellucida with continuous 0.2 ms pulses applied from the 1-5 o'clock positions. MAIN OUTCOME MEASURES: The primary outcome was the live birth rate. Secondary end points included clinical pregnancy, miscarriage, multiple pregnancies, preterm births, obstetric and neonatal complications, and congenital anomalies. RESULTS: Overall, 698 participants met the inclusion criteria and were randomized: 352 patients were assigned to the AH arm and 346 to the control arm. Of the participants, 105 (29.8%) and 101 (29.2%), respectively, achieved a live birth after treatment. The relative risk of live birth in patients with vitrified/warmed blastocysts treated with AH was 1.02 (95% confidence interval, 0.86-1.19). Exploratory subgroup analyses for women's age, recruiting centers, indications for in vitro fertilization, method of insemination, blastocyst quality, and days of blastocyst development failed to highlight any clinical situation that could benefit from AH in thawed blastocysts. CONCLUSION: In patients undergoing frozen embryo transfer with vitrified/warmed blastocysts, laser AH does not improve the live birth rate. Further studies are required to rule out milder but potentially interesting benefits in specific subgroups of patients. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03623659.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Alteri A, Reschini M, Guarneri C, et al. The effect of laser-assisted hatching on vitrified/warmed blastocysts: the ALADDIN randomized controlled trial. Fertil Steril. 2024. PMID: 38342371. doi:10.1016/j.fertnstert.2024.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。